ATLAS Market profile
Menu
Atlas · Symbols · Stocks & Shares · ICL

Atlas market file · Equity · United States

ICL Group Ltd.ICL

Last close
5.27
Change
+0.76%
96-bar range
4.825 – 6.97
As of
6 Aug 2026

ICL Group Ltd. is an agricultural chemicals issuer listed as ICL on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot NYSE:ICL

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

7.03436.46595.89755.32914.760620 Mar29 May06 Aug

up candle   down candle

Latest close5.27
Day change+0.76%
Window high6.97
Window low4.825
96-bar change+6.90%
SnapshotDaily · 96 bars
As of2026-08-06 13:30 UTC

Weekly outlook: the last 104 weekly closes (+20.05% over the window).

7.45043.659619 Aug06 Aug

Source rail: Yahoo Finance chart API (ICL). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for ICL. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

ICL public profile

Company

Agricultural chemicals issuer. ICL Group Ltd. is connected to current market context, cited company sources and its retained research file.

Market

ICL Group Ltd. trades as ICL on NYSE. ICL Group Ltd. (ICL) has a latest verified close of 5.27, up 0.76%, dated 6 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files ICL under USA Stocks for browsing.

Institutional Market Wit ● Sourced Research File

ICL's animal feed division is busy calculating how many moo-velous magnesium oxide scoops it takes to turn a dairy cow into a four-legged dividend machine. The company's premium vitamins and minerals are allegedly maximizing milk production, growth, and reproduction-though the balance sheet's 'milk yield per share' metric remains stubbornly silent. Meanwhile, Methyl Bromide is still fumigating soil like it's 1989, proving that sustainability in agchem sometimes means sticking to the script even when the EPA's pen is poised to rewrite it. (source: ICL Group: Ingredients for Animal Food and Space Fumigation, https://www.icl-group.com/our-business/products-for-animals/)

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for ICL Group Ltd. today

Open full report
ICL daily contextvalidated public digest5 source rail2026-08-07 02:40 UTC

ICL Group (ICL) reported its Full Year 2024 results, touting growth in animal feed additives and energy storage chemicals, though specifics remain scarce in the provided evidence. The company’s core offerings-magnesium oxide for cattle, phosphates for coatings, and bromine for batteries-reflect a diversified but low-margin portfolio straddling agriculture and industrial chemicals.

ICL’s AgTech arm, which includes "e-learning tools" and fertilizer management apps, appears to be a digital overlay on traditional commodity sales. Their "innovative" software tools are described in vagueness, suggesting a platform still searching for a scalable revenue model beyond physical product sales. Notably, the company’s bromine division, supplying materials for flow batteries, has yet to translate niche applications into dominant revenue streams.

The evidence includes mentions of "state-of-the-art R&D facilities" but no filed figures on R&D spend or patent approvals. ICL’s "controlled-release fertilizers" are framed as sustainable breakthroughs, though similar claims from competitors have historically struggled to command premium pricing. The absence of concrete financial metrics in the supplied rail limits the ability to assess growth claims.

ICL’s products are deeply tied to cyclical industries: animal feed demand fluctuates with livestock prices, while bromine markets depend on energy policy shifts. The company’s reliance on commodity pricing and regulatory tailwinds introduces volatility that its polished sustainability narrative does not fully address.

Sources & evidence · 5 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
ICL
Exchange
NYSE
Sector
Us Public Equity Directory
Region
United States
Asset class
Equity
Directory source
Nasdaq Trader
SEC CIK
TradingView

ICL technical readout

Trend strength (ADX 14)
21.2
Average true range (ATR 14)
0.1361
ATR as % of price
2.60%
Volatility compression (ATR14/ATR50)
0.87x

Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.

Source authority

ICL evidence rails

Atlas uses the specific public rails available for ICL: SEC EDGAR, Nasdaq Trader, TradingView, FRED. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 5 rails

Open an Atlas research path on ICL

FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for ICL Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep ICL research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

ICL FAQ

What is ICL Group Ltd. (ICL)?ICL Group Ltd. (ICL) has a latest verified close of 5.27, up 0.76%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates,...

ICL Group Ltd. (ICL) has a latest verified close of 5.27, up 0.76%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for ICL?ICL Group Ltd. (ICL) has a latest verified close of 5.27, up 0.76%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and...

ICL Group Ltd. (ICL) has a latest verified close of 5.27, up 0.76%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files ICL under USA Stocks for browsing.

How often is the ICL page updated?The ICL public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The ICL public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for ICL?The ICL file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:ICL. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...

The ICL file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:ICL. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on ICL?Yes. The workstation can open ICL, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open ICL, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this ICL page investment advice?No. The ICL page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The ICL page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →